Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MODIFIED OLIGONUCLEOTIDE
Document Type and Number:
WIPO Patent Application WO/2007/094218
Kind Code:
A1
Abstract:
A modified oligonucleotide comprising an oligonucleotide containing at its 3’end a modified nucleoside as a structural component, wherein the modified nucleoside is one having a carboxylic acid or steroid skeleton containing compound linked via a linker to the 3’end of nucleoside. The modified oligonucleotide can be produced by solid-phase synthesis using any of the unit compounds for solid-phase synthesis represented by the formula (XIA) or the unit compounds for solid-phase synthesis represented by the formula (XIS) as a starting material. (XIA) (XIS) wherein R1, R2, n, m, RA and RS are as defined in the description.

Inventors:
KITADE YUKIO
UENO YOSHIHITO
WATAYA YUSUKE
Application Number:
PCT/JP2007/052129
Publication Date:
August 23, 2007
Filing Date:
February 07, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV GIFU (JP)
UNIV OKAYAMA NAT UNIV CORP (JP)
KITADE YUKIO
UENO YOSHIHITO
WATAYA YUSUKE
International Classes:
C07H21/04; C07J9/00; C12N15/09
Domestic Patent References:
WO1995023162A11995-08-31
Foreign References:
JPH06500556A1994-01-20
JPS62277395A1987-12-02
JPS61238797A1986-10-24
JPH0995495A1997-04-08
Other References:
SOUTSCHEK J. ET AL.: "Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs", NATURE, vol. 432, 2004, pages 173 - 178, XP002336040
KAWASAKI A.M. ET AL.: "Uniformly Modified 2'-Deoxy-20-fluoro Phosphorothioate Oligonucleotides as Nuclease-Resistant Antisense Compounds with High Affinity and Specificity for RNA Targets", JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, no. 7, 1993, pages 831 - 841, XP000562792
Attorney, Agent or Firm:
IKEUCHI SATO & PARTNER PATENT ATTORNEYS (OAP TOWER 8-30, Tenmabashi 1-chome, Kita-k, Osaka-shi Osaka 26, JP)
Download PDF: